Retraction notice to "Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years" [Brain Behav. Immun. 32 (2013) 153-158];Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years

Brain, Behavior, and Immunity

Volumn 32, Issue , 2013, Pages 153-158

  Kern, Silke ^a   Skoog, Ingmar ^a   Börjesson Hanson, Anne ^a   Blennow, Kaj ^a   Zetterberg, Henrik ^a   Östling, Svante ^a   Kern, Jürgen ^a   Gudmundsson, Pia ^a   Marlow, Thomas ^a   Rosengren, Lars ^a   Waern, Margda ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CSF; Depression; Interleukin 6; Older women; Population based; Prospective

Indexed keywords

ANTIDEPRESSANT AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CEREBROSPINAL FLUID; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHOPHARMACOTHERAPY; VERY ELDERLY;

EID: 84891371746     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.11.011     Document Type: Erratum

References (44)

1. Asberg, M., Montgomery, S.A., et al., 1978. A comprehensive psychopathological rating scale. Acta Psychiatr. Scand. Suppl. 271, 5-27.
2. Banks, W.A., Kastin, A.J., et al., 1994. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179 (1-2), 53-56.
3. Baune, B.T., Smith, E., et al., 2012. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney memory and aging study. Psychoneuroendocrinology 37 (9), 1521-1530.
4. Bengtsson, C., Blohme, G., et al., 1973. The study of women in Gothenburg 1968-1969-a population study. General design, purpose and sampling results. Acta Med. Scand. 193 (4), 311-318.
5. Beumer, W., Gibney, S.M., et al., 2012. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 92 (5), 959-975.
6. Blum-Degen, D., Muller, T., et al., 1995. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202 (1-2), 17-20.
7. Buchhave, P., Minthon, L., et al., 2012. Cerebrospinal fluid levels of beta-Amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiatry 69 (1), 98-106.
8. Carpenter, L.L., Heninger, G.R., et al., 2004. Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. J. Affect Disord. 79 (1-3), 285-289.
9. Chaouloff, F., 2000. Serotonin, stress and corticoids. J. Psychopharmacol. 14 (2), 139-151.
10. Dantzer, R., 2012. Depression and inflammation: an intricate relationship. Biol. Psychiatry 71 (1), 4-5.
11. Dilger, R.N., Johnson, R.W., 2008. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol. 84 (4), 932-939.
12. Dowlati, Y., Herrmann, N., et al., 2010. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67 (5), 446-457.
13. Duivis, H.E., de Jonge, P., et al., 2011. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am. J. Psychiatry 168 (9), 913-920.
14. Dunn, A.J., 2006. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res. 6 (1-2), 52-68.
15. Folstein, M.F., Folstein, S.E., et al., 1975. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (3), 189-198.
16. Gimeno, D., Kivimaki, M., et al., 2009. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39 (3), 413-423.
17. Gudmundsson, P., Skoog, I., et al., 2007. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am. J. Geriatr. Psychiatry 15 (10), 832-838.
18. Hopkins, S.J., Rothwell, N.J., 1995. Cytokines and the nervous system. I: expression and recognition. Trends Neurosci. 18 (2), 83-88.
19. Howren, M.B., Lamkin, D.M., et al., 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71 (2), 171-186.
20. Kiecolt-Glaser, J.K., Preacher, K.J., et al., 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100 (15), 9090-9095.
21. Kronfol, Z., Remick, D.G., 2000. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157 (5), 683-694.
22. Leonard, B., 2000. Stress, depression and the activation of the immune system. World J. Biol. Psychiatry 1 (1), 17-25.
23. Levine, J., Barak, Y., et al., 1999. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40 (4), 171-176.
24. Lindqvist, D., Janelidze, S., et al., 2009. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 66 (3), 287-292.
25. Maier, S.F., Watkins, L.R., 1998. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105 (1), 83-107.
26. Martinez, J.M., Garakani, A., et al. 2011. Proinflammatory and "resiliency" proteins in the CSF of patients with major depression. Depress Anxiety 2012 Jan; 29 (1), 32-38.
27. Miller, A.H., Maletic, V., et al., 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65 (9), 732-741.
28. Montgomery, S.A., Asberg, M., 1979. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382-389.
29. Mossner, R., Mikova, O., et al., 2007. Consensus paper of the WFSBP task force on biological markers: biological markers in depression. World J. Biol. Psychiatry 8 (3), 141-174.
30. Norden, D.M., Godbout, J.P., 2013. Microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. 39 (1), 19-34.
31. O'Brien, S.M., Scott, L.V., et al., 2004. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum. Psychopharmacol. 19 (6), 397-403.
32. O'Connor, M.F., 2009. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 23 (7), 887-897.
33. Oslo, N., 1997. World Health Organization Collaborating Center for Drug Statistics Methodology Anatomical Therapeutic Chemical (ATC) Classification Index. World Health Organization.
34. Palsson, S., Larsson, L., et al., 2001. The prevalence of depression in relation to cerebral atrophy and cognitive performance in 70-and 74-year-old women in Gothenburg. The women's health study. Psychol. Med. 31 (1), 39-49.
35. Raison, C.L., Borisov, A.S., et al., 2009. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol. Psychiatry 65 (4), 296-303.
36. Rapp, M.A., Hellweg, R., et al., 2011. The importance of depressive syndromes for incipient Alzheimer-type dementia in advanced age. Nervenarzt 82 (9), 1140-1144.
37. Schrepf, A., Clevenger, L., et al. 2013. Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability. Brain Behav. Immun. 2013 Mar; 30 Suppl:S126-34.
38. Skoog, I., Nilsson, L., et al., 1993. A population-based study of dementia in 85-yearolds. N. Engl. J. Med. 328 (3), 153-158.
39. Stewart, J.C., Rand, K.L., et al., 2009. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav. Immun. 23 (7), 936-944.
40. Stubner, S., Schon, T., et al., 1999. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neurosci. Lett. 259 (3), 145-148.
41. Tarkowski, E., Blennow, K., et al., 1999. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19 (4), 223-230.
42. Tarkowski, E., Liljeroth, A.M., et al., 2003. Cerebral pattern of pro-and anti-inflammatory cytokines in dementias. Brain Res. Bull. 61 (3), 255-260.
43. Whooley, M.A., Caska, C.M., et al., 2007. Depression and inflammation in patients with coronary heart disease: findings from the heart and soul study. Biol. Psychiatry 62 (4), 314-320.
44. Vogelzangs, N., Duivis, H.E., et al., 2012. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Trans. Psychiatry 2, e79.